Literature DB >> 21620685

SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.

Yanhua Liang1, John P Sundberg.   

Abstract

BACKGROUND: The chronic proliferative dermatitis mutation (CPDM) in mice, due to Sharpin deficiency (Sharpin(cpdm)), is a multisystem disorder characterized by peripheral blood eosinophilia and eosinophil infiltration of affected tissues including the skin, bone marrow, spleen, lung, heart, and other organs. The epidermis has numerous apoptotic keratinocytes which increase with age, coalesce, form vesicles, and rupture causing ulceration.
OBJECTIVE: To clarify the molecular pathways involved in the keratinocyte apoptosis caused by loss of function of SHARPIN in mice.
METHOD: 10-week-old Sharpin(cpdm) and wildtype mice were used for experiments. Ultrastructural changes of skin were evaluated by transmission electron microscopy. Cross points of mitochondrial pathway were analyzed by in vitro and in vivo cellular and molecular assays.
RESULTS: 77.5% skin cells in Sharpin(cpdm) mice were functionally apoptotic and dead cells, compared to only 18.1% unhealthy skin cells in wildtype mice, indicated by annexin-V/propidium iodide FACS analysis. Mitochondria in keratinocytes were disrupted containing prominent electron dense inclusions and membrane potential depolarization, accompanied by a shift in protein expression between the anti-apoptotic BCL2 and pro-apoptotic BAX proteins. Enzymatic activities of caspases 9 and 3, but not 8, were markedly increased in Sharpin(cpdm) keratinocytes. Caspase-3 was cleaved in most cells in skin of 10-week-old mutant mice.
CONCLUSION: The present results indicated that keratinocyte apoptosis in Sharpin(cpdm) mice was regulated by an intrinsic caspase-dependent mitochondria pathway.
Copyright © 2011 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620685      PMCID: PMC3152647          DOI: 10.1016/j.jdermsci.2011.04.012

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  31 in total

1.  Apoptosis: the skin from a new perspective.

Authors:  R R Polakowska; A R Haake
Journal:  Cell Death Differ       Date:  1994-07       Impact factor: 15.828

2.  Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12.

Authors:  H HogenEsch; S E Torregrosa; D Boggess; B A Sundberg; J Carroll; J P Sundberg
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

Review 3.  Animal models of psoriasis - what can we learn from them?

Authors:  M P Schön
Journal:  J Invest Dermatol       Date:  1999-04       Impact factor: 8.551

4.  Changes in keratin and filaggrin expression in the skin of chronic proliferative dermatitis (cpdm) mutant mice.

Authors:  H HogenEsch; D Boggess; J P Sundberg
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

5.  Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis.

Authors:  R E Seymour; M G Hasham; G A Cox; L D Shultz; H Hogenesch; D C Roopenian; J P Sundberg
Journal:  Genes Immun       Date:  2007-05-31       Impact factor: 2.676

6.  Ultrastructure of epidermis of mice with chronic proliferative dermatitis.

Authors:  M J Gijbels; H HogenEsch; B Blauw; P Roholl; C Zurcher
Journal:  Ultrastruct Pathol       Date:  1995 Mar-Apr       Impact factor: 1.094

Review 7.  Mouse models of psoriasis.

Authors:  Johann E Gudjonsson; Andrew Johnston; Melissa Dyson; Helgi Valdimarsson; James T Elder
Journal:  J Invest Dermatol       Date:  2007-04-12       Impact factor: 8.551

8.  Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.

Authors:  Xue-Jun Zhang; Wei Huang; Sen Yang; Liang-Dan Sun; Feng-Yu Zhang; Qi-Xing Zhu; Fu-Ren Zhang; Chi Zhang; Wen-Hui Du; Xiong-Ming Pu; Hui Li; Feng-Li Xiao; Zai-Xing Wang; Yong Cui; Fei Hao; Jie Zheng; Xue-Qin Yang; Hui Cheng; Chun-Di He; Xiao-Ming Liu; Li-Min Xu; Hou-Feng Zheng; Shu-Mei Zhang; Jian-Zhong Zhang; Hong-Yan Wang; Yi-Lin Cheng; Bi-Hua Ji; Qiao-Yun Fang; Yu-Zhen Li; Fu-Sheng Zhou; Jian-Wen Han; Cheng Quan; Bin Chen; Jun-Lin Liu; Da Lin; Li Fan; An-Ping Zhang; Sheng-Xiu Liu; Chun-Jun Yang; Pei-Guang Wang; Wen-Ming Zhou; Guo-Shu Lin; Wei-Dong Wu; Xing Fan; Min Gao; Bao-Qi Yang; Wen-Sheng Lu; Zheng Zhang; Kun-Ju Zhu; Song-Ke Shen; Min Li; Xiao-Yan Zhang; Ting-Ting Cao; Wei Ren; Xin Zhang; Jun He; Xian-Fa Tang; Shun Lu; Jian-Qiang Yang; Lin Zhang; Dan-Ni Wang; Feng Yuan; Xian-Yong Yin; Hong-Jie Huang; Hai-Feng Wang; Xin-Yi Lin; Jian-Jun Liu
Journal:  Nat Genet       Date:  2009-01-25       Impact factor: 38.330

Review 9.  The CD95(APO-1/Fas) DISC and beyond.

Authors:  M E Peter; P H Krammer
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

10.  Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.

Authors:  Rajan P Nair; Kristina Callis Duffin; Cynthia Helms; Jun Ding; Philip E Stuart; David Goldgar; Johann E Gudjonsson; Yun Li; Trilokraj Tejasvi; Bing-Jian Feng; Andreas Ruether; Stefan Schreiber; Michael Weichenthal; Dafna Gladman; Proton Rahman; Steven J Schrodi; Sampath Prahalad; Stephen L Guthery; Judith Fischer; Wilson Liao; Pui-Yan Kwok; Alan Menter; G Mark Lathrop; Carol A Wise; Ann B Begovich; John J Voorhees; James T Elder; Gerald G Krueger; Anne M Bowcock; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2009-01-25       Impact factor: 38.330

View more
  18 in total

Review 1.  E3 ubiquitin ligases in B-cell malignancies.

Authors:  Jaewoo Choi; Luca Busino
Journal:  Cell Immunol       Date:  2019-02-26       Impact factor: 4.868

2.  Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.

Authors:  Rosalind L Ang; Mark Chan; Diana Legarda; John P Sundberg; Shao-Cong Sun; Virginia L Gillespie; Nicholas Chun; Peter S Heeger; Huabao Xiong; Sergio A Lira; Adrian T Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

3.  SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex.

Authors:  Yoon Park; Hyung-Seung Jin; Justine Lopez; Jeeho Lee; Lujian Liao; Chris Elly; Yun-Cai Liu
Journal:  Nat Immunol       Date:  2016-02-01       Impact factor: 25.606

Review 4.  SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?

Authors:  Dhanya Krishnan; Ramsekhar N Menon; Srinivas Gopala
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

5.  Chronic Proliferative Dermatitis in Mice: NFκB Activation Autoinflammatory Disease.

Authors:  Yanhua Liang
Journal:  Patholog Res Int       Date:  2011-06-01

6.  SHARPIN negatively associates with TRAF2-mediated NFκB activation.

Authors:  Yanhua Liang
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

7.  SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells.

Authors:  Zhe Wang; Anna Sokolovska; Rosemarie Seymour; John P Sundberg; Harm Hogenesch
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

8.  Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk.

Authors:  Jason De Melo; Damu Tang
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

9.  Effects of T-cadherin expression on B16F10 melanoma cells.

Authors:  Xin-Suo Duan; Jie Lu; Zhi-Hua Ge; En-Hong Xing; Hai-Tao Lu; Li-Xin Sun
Journal:  Oncol Lett       Date:  2013-01-30       Impact factor: 2.967

10.  Nrf2/ARE Pathway Involved in Oxidative Stress Induced by Paraquat in Human Neural Progenitor Cells.

Authors:  Tingting Dou; Mengling Yan; Xinjin Wang; Wen Lu; Lina Zhao; Dan Lou; Chunhua Wu; Xiuli Chang; Zhijun Zhou
Journal:  Oxid Med Cell Longev       Date:  2015-11-15       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.